Business
Jim Cramer's View on Eli Lilly
Financial analyst Jim Cramer discusses his views on Eli Lilly, suggesting the stock has seen a significant run-up and may be overvalued.
Coverage timeline — 1 article
CNBC
"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.
2026-06-08 17:10 UTC